" class="no-js "lang="en-US"> Blueberry Therapeutics - Medtech Alert
Sunday, February 05, 2023
Blueberry Therapeutics | Pharmtech Focus

Blueberry Therapeutics

About Blueberry Therapeutics

Blueberry Therapeutics

Blueberry Therapeutics Ltd. is a modern drug discovery and development company which puts people first whether patients, employees, investors or partners. We have created an open, imaginative and fun team environment with a very serious objective: to create new, safer and more effective medicines to treat human disease and make patients feel better.

Blueberry focuses on the research and development of treatments for skin diseases. We do this by employing state of the art preclinical research technologies to generate potent selective and safe molecules (peptides, antibodies, small molecules) for clinical development into new effective treatments to benefit patients. By focusing on well validated drug targets and ensuring our candidate molecules have a very low toxicity liability we believe we can mitigate or even avoid two of the major reasons for drug failures in the clinic.

In the clinic, Blueberry uses smart, agile, clinical designs to deliver high quality trials more rapidly and with reduced development costs.

Blueberry will rapidly progress new therapies to clinical proof-of-concepts and beyond with appropriate, effective and safe doses with full regulatory and ethical approval.

We have programs addressing Onychomycosis, Tinea Pedis, Acne and Atopic Dermatitis.

Related Story

Blueberry Therapeutics Secures £750,000 Investment from NPIF - Maven Equity Fund

June 9 2021

NPIF – Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the […]